Zhou KI - Search Results

1

Breast cancer exploits neural signaling pathways for bone-to-meninges metastasis.

Whiteley AE, Ma D, Wang L, Yu SY, Yin C, Price TT, Simon BG, Xu KR, Marsh KA, Brockman ML, Prioleau TM, Zhou KI, Cui X, Fecci PE, Jeck WR, McCall CM, Neff JL, Sipkins DA. Whiteley AE, et al. Among authors: zhou ki. Science. 2024 Jun 21;384(6702):eadh5548. doi: 10.1126/science.adh5548. Epub 2024 Jun 21. Science. 2024. PMID: 38900896

2

Dasatinib-associated follicular lymphoma in a patient with B-cell acute lymphoblastic leukaemia.

Zhou KI, Lin C, Neff JL, Galal A. Zhou KI, et al. BMJ Case Rep. 2023 May 17;16(5):e252739. doi: 10.1136/bcr-2022-252739. BMJ Case Rep. 2023. PMID: 37197831

3

Comprehensive Genomic Profiling in Non-Myeloid Hematologic Malignancies Identifies Variants That Can Alter Clinical Practice.

Lin C, Zhou KI, Green MF, Caughey BA, Strickler JH, Datto MB, McKinney MS. Lin C, et al. Among authors: zhou ki. Hematol Rep. 2024 Sep 30;16(4):603-611. doi: 10.3390/hematolrep16040059. Hematol Rep. 2024. PMID: 39449302 Free PMC article.

4

Utility of Tumor Mutational Burden as a Biomarker for Response to Immune Checkpoint Inhibition in the VA Population.

Scobie MR, Zhou KI, Ahmed S, Kelley MJ. Scobie MR, et al. Among authors: zhou ki. JCO Precis Oncol. 2023 Sep;7:e2300176. doi: 10.1200/PO.23.00176. JCO Precis Oncol. 2023. PMID: 38039430

5

2'-O-methylation (Nm) in RNA: progress, challenges, and future directions.

Zhou KI, Pecot CV, Holley CL. Zhou KI, et al. RNA. 2024 Apr 16;30(5):570-582. doi: 10.1261/rna.079970.124. RNA. 2024. PMID: 38531653 Free PMC article. Review.

6

Management of Microsatellite Instability High (MSI-H) Gastroesophageal Adenocarcinoma.

Zhou KI, Hanks BA, Strickler JH. Zhou KI, et al. J Gastrointest Cancer. 2024 Jun;55(2):483-496. doi: 10.1007/s12029-023-01003-5. Epub 2023 Dec 22. J Gastrointest Cancer. 2024. PMID: 38133871 Review.

7

Real-world Experience With Neurotrophic Tyrosine Receptor Kinase Fusion-positive Tumors and Tropomyosin Receptor Kinase Inhibitors in Veterans.

Zhou KI, Vashistha V, Guo A, Ahmed S, Kelley MJ. Zhou KI, et al. JCO Precis Oncol. 2023 Mar;7:e2200692. doi: 10.1200/PO.22.00692. JCO Precis Oncol. 2023. PMID: 36926986

8

Reply to M.S. Brose et al.

Zhou KI, Kelley MJ. Zhou KI, et al. JCO Precis Oncol. 2023 Sep;7:e2300275. doi: 10.1200/PO.23.00275. JCO Precis Oncol. 2023. PMID: 37769222 Free PMC article. No abstract available.

9

Surprise diagnosis of acquired von Willebrand syndrome in a patient previously thought to have type III von Willebrand disease: evaluation and periprocedural management.

Zhou KI, Kapoor S, Onwuemene OA. Zhou KI, et al. BMJ Case Rep. 2023 Dec 6;16(12):e257760. doi: 10.1136/bcr-2023-257760. BMJ Case Rep. 2023. PMID: 38056930

10

Targeting Claudin-18.2 for cancer therapy: updates from 2024 ASCO annual meeting.

Zhou KI, Strickler JH, Chen H. Zhou KI, et al. J Hematol Oncol. 2024 Aug 26;17(1):73. doi: 10.1186/s13045-024-01595-w. J Hematol Oncol. 2024. PMID: 39183320 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters